Two regulators grade your pen testing program. Only one of them is the FDA.
- +50% jump in FDA CDER warning letters in FY2025
- 6 to 18 months of attacker dwell time in documented pharma breaches
- ~30 multinational pharma, manufacturing and energy firms hit in one APT41 campaign
Inside this ebook: Two ready-to-use frameworks. The GxP-IP Dual Scoping Matrix lets you satisfy the FDA and protect your IP in one engagement. The Pharma Threat Exposure Index gives you a 100-point score that shows your board exactly where you stand.
